HER2 Receptor and Bcr-Abl by Kevin Ahern, PhD

video locked

About the Lecture

The lecture HER2 Receptor and Bcr-Abl by Kevin Ahern, PhD is from the course Hormones and Signal Transduction. It contains the following chapters:

  • HER2 Receptor
  • Other Mutations – Bcr-Abl

Included Quiz Questions

  1. It is inhibited by trastuzumab/herceptin.
  2. It is an intracellular receptor.
  3. It promotes apoptosis in malignant cells.
  4. It is never expressed in malignant cells.
  1. It creates a tyrosine kinase that is inhibited by imatinib.
  2. It is a tyrosine kinase that is activated by translocation between chromosomes 11 and 22.
  3. It is treated with imatinib, a GTPase inhibitor.
  4. It is caused by a translocation between chromosomes 15 and 19.
  1. It is carried on chromosome 22 and formed by the reciprocal translocation of genetic material between chromosome 9 and chromosome 22.
  2. It is carried on chromosome 9 and formed by the reciprocal translocation of genetic material between chromosome 9 and chromosome 22.
  3. It is carried on chromosome 19 and is formed by the reciprocal translocation of genetic material between chromosome 19 and chromosome 22.
  4. It is carried on chromosome 22 and is formed by the reciprocal translocation of genetic material between chromosome 6 and chromosome 22.
  5. It is carried on chromosome 6 and is formed by the reciprocal translocation of genetic material between chromosome 6 and chromosome 22.

Author of lecture HER2 Receptor and Bcr-Abl

 Kevin Ahern, PhD

Kevin Ahern, PhD


Customer reviews

(1)
5,0 of 5 stars
5 Stars
1
4 Stars
0
3 Stars
0
2 Stars
0
1  Star
0
 
All this concepts are difficult to explain but with the method that you apply is easy to understand
By Lucero O. on 05. March 2019 for HER2 Receptor and Bcr-Abl

Was very clear just speak very quickly, then I have to repeat the lesson to understand complete anyway its not important, I would like just when speaking about the oncogenes give some examples about the food that causes